Average cost of drugs for extensively drug-resistant tuberculosis in Iraq
Iraq: Average cost of drugs for extensively drug-resistant tuberculosis was 2,000 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
2,000 constant 2022 US$
Change on year
up 100.0%
World rank
24th
of 56 countries
All-time high
4,000 constant 2022 US$
in 2018
All-time low
1,000 constant 2022 US$
in 2022
Years of data
7
2018–2024
Average cost of drugs for extensively drug-resistant tuberculosis in Iraq, 2018–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of drugs for extensively drug-resistant tuberculosis in Iraq stood at 2,000 constant 2022 US$.
That represents a change of up 100.0% on the previous year and down 50.0% over ten years.
Iraq ranks 24th of 56 countries on this measure, in the middle of the range.
Average cost of drugs for extensively drug-resistant tuberculosis in Iraq, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2018 | 4,000 constant 2022 US$ | — |
| 2019 | 4,000 constant 2022 US$ | +0.0% |
| 2020 | 4,000 constant 2022 US$ | +0.0% |
| 2021 | 4,000 constant 2022 US$ | +0.0% |
| 2022 | 1,000 constant 2022 US$ | -75.0% |
| 2023 | 1,000 constant 2022 US$ | +0.0% |
| 2024 | 2,000 constant 2022 US$ | +100.0% |
Iraq compared with similar countries
- Iraq's 2,000 constant 2022 US$ is above the median for upper middle income countries, which is 2,000 constant 2022 US$, 1.0× the median. (23 countries reporting)
- Iraq's 2,000 constant 2022 US$ is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 2,000 constant 2022 US$, 1.0× the median. (7 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 4,000 constant 2022 US$ | 4,000 constant 2022 US$ | 4,000 constant 2022 US$ | 2 |
| 2020s | 2,400 constant 2022 US$ | 1,000 constant 2022 US$ | 4,000 constant 2022 US$ | 5 |
Countries ranked near Iraq
More reference data data for Iraq
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.2116 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 3.19 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 7.23 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.3911 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 7.23 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.7096 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.235 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 13.21 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 30.36 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 2.13 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Iraq?
- Average cost of drugs for extensively drug-resistant tuberculosis in Iraq was 2,000 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Iraq?
- The highest recorded value was 4,000 constant 2022 US$ in 2018.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Iraq?
- The lowest recorded value was 1,000 constant 2022 US$ in 2022.
- How does Iraq rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Iraq ranks 24th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Iraq?
- Over the last ten years it is down 50.0%. The long-run trend across the full record is falling.
- Where does this Iraq data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.